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ABSTRACT 
Mitochondrial NEET proteins are recently discovered iron-sulfur proteins that are 
localized within mitochondria.  There are three NEET proteins: mitoNEET, a type II diabetes 
drug pioglitazone binding target, a mitoNEET related protein 1 (Miner1 or NAF-1), and a 
mitoNEET-related protein 2 (Miner2).  While both mitoNEET and Miner1 are mitochondrial 
outer membrane proteins, Miner2 is a mitochondrial matrix protein.  All three NEET proteins 
bind at least one [2Fe-2S] cluster via CDGSH (Cys-Asp-Gly-Ser-His) motif.  In this work, we 
have investigated the electron transfer activity of mitoNEET, and found that the CDGSH-type 
[2Fe-2S] clusters of mitoNEET can be reduced by the reduced flavin mononucleotide (FMNH2)  
under anaerobic or aerobic conditions in vitro. We have also found that the reduced mitoNEET 
[2Fe-2S] clusters can be oxidized by ubiquinone or oxygen. Further studies have demonstrated 
that the type II diabetes medication pioglitazone may compete for the FMNH2 binding site of 
mitoNEET, and inhibit the reduction of the mitoNEET [2Fe-2S] clusters by FMNH2. We have 
also described the inhibitory effect of nitric oxide on the electron transfer activity of the 
mitochondrial matric protein Miner2. We have found that nitric oxide can bind to the reduced 
Miner2 [2Fe-2S] clusters without disruption of the cluster, and that visible light excitation can 
quickly release nitric oxide from the nitric oxide-bound cluster in Miner2. Binding of nitric oxide 
effectively inhibits the electron transfer activity of the Miner2 [2Fe-2S] clusters.  The results 
suggest that mitochondrial NEET-proteins may play a novel role in energy metabolism in cells, 
and that nitric oxide may regulate the electron transfer activity of the NEET-proteins and 
modulate the energy metabolism in mitochondria via directly binding to the [2Fe-2S] clusters in 
the proteins.
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CHAPTER 1. INTRODUCTION 
1.1 Iron-sulfur Clusters 
Iron-sulfur clusters (ISC) are one of the most ancient and conservative cofactors (1). 
More than 500 distinct proteins with versatile forms of ISC have been found in achaea, bacteria, 
and eukaryotes, since ferredoxin, the first known ISC containing protein, was found in 1960s (2-
3). 
There are various numbers of Fe and S atoms in different forms of ISC.  The most 
common forms of ISC are the [2Fe-2S] clusters and the [4Fe-4S] clusters (Figure 1.1) (4). The 
[2Fe-2S] and [4Fe-4S] are generally ligated to proteins through cysteine residue. In some cases, 
aspartate, histidine, or serine can also be the ligands for the iron-sulfur clusters in proteins (5). 
The primary biological function of the ISC is electron transfer, as the Fe in ISC can be 
both electron acceptor and donor (6). For example, a chain of ISC in the complex I of 
mitochondria transfer electrons from NADH in matrix to the ubiquinone embedded in the 
mitochondrial inner membrane (7). The second role of ISC is to serve as the active center in an 
enzyme. For example, fumarase A from Escherichia coli, catalyzes the reversible 
hydration/dehydration of fumarate holds a [4Fe-4S] in its active center (8). The third function of 
ISC is the regulation of gene expression.  The examples are bacterial transcription factors SoxR, 
FNR, IRP, IscR (9-11).  
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Figure 1.1 Structures, core oxidation states, and spin states of crystallographically defined [Fe-S] 
clusters.  
Iron is shown in red, and sulfur is shown in yellow. The spin state, denoted by a question mark, 
has yet to be determined. The [3Fe-4S] cluster has only been observed as a fragment in 
heterometallic [M-3Fe-4S]+ clusters (not shown) in which M is a divalent transition metal ion 
(3). 
 
1.2 CDGSH-type iron-sulfur domain-containing proteins  
The CDGSH Iron-Sulfur domain (CISD) is a type of ancient and widely distributed motif 
that are found in the three domains of life. This motif is characterized by a highly conserved 
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seventeen amino acid sequence [C-X-C-X2-(S/T)-X3-P-X-C-D-G-(S/A/T)-H], in which the 
[2Fe-2S] cluster is coordinated with unique three cysteine residues (3Cys) and one histidine 
(1His) in proteins (14-18). The most important character of this 3Cys-1His domain is that the 
ISC attached to it has a higher redox midpoint potential and relatively lower binding stability.  
Thus, it may serve as an electron donor or the ISC donor (19-31). The versatile function of the 
CISD proteins may explain why they widely appear in bacteria, archaea, and eukaryotic cells 
(Figure.1.2). 
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Figure.1.2 Phylogenetic distribution of CISDs. (14) 
  
1.3 Human NEET-protein family and related diseases 
There are three CISD proteins, mitoNEET, Miner1, and Miner2, encoded by gene 
CISD1, CISD2, and CISD3 respectively in human mitochondira. The first member of NEET 
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family, mitoNEET, was discovered during the screening for the mitochondrial binding targets of 
the type II diabetes Pioglitazone (32). MitoNEET was named by its mitochondrial localization 
(mito), and a sequence of amino acid residues ASN-Glu-Glu-Thr (NEET) (15).  The rest of the 2 
NEET-protein family members were named Miner1/2 meaning mitoNEET related 1/2 initially.  
The three NEET family proteins share the CDGSH motif that holds a [2Fe-2S] clusters (16). The 
UV-vis spectra of mitoNEET, Miner1, and Miner2 show great similarity (Figure.1.3) (33). 
Further structure studies have shown that mitoNEET and Miner1 are homodimer, with 
one CISD on each peptide chain, whereas Miner2 has two CISDs, each holding one [2Fe-2S] 
cluster (17-18) (33). Both mitoNEET and Miner1 are lipid anchored proteins. MitoNEET is 
anchored to the mitochondrial outer membrane via its N-terminal domain.  The C-terminal 
domain binds a [2Fe-2S] cluster and is exposed to cytosol (32).  The mitoNEET homolog Miner1 
is mainly associated with the endoplasmic reticulum (ER), with some in the mitochondrial outer 
membrane (35). Miner2 is a soluble protein in the matrix (36-37). Extensive studies have shown 
that mitoNEET and Miner1 play key roles in maintaining cellular iron content and production of 
reactive oxygen species (ROS). MitoNEET was found to have a key role in in mitochondrial 
morphology maintaining, cancer cell proliferation, lipid and glucose homeostasis in obesity and 
diabetes. The mutations of Miner1 have been associated with the Wolfram Syndrome 2, a genetic 
neurological disorder (38-48). The biological function of Miner2, however, is currently 
unknown.  
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Fig. 1.3 Human NEET protein alignments and UV–vis spectra.  
(A) Amino acids conserved in humans are shown in gray. Amino acids that coordinate to the 
2Fe –2S clusters are shown in yellow. The 16 amino acid cluster binding domains are boxed in 
magenta. Note that Miner2 has a repeat of the 16 amino acid 2Fe–2S cluster binding domain, 
underlined in pink. The transmembrane domains of mitoNEET and NAF-1 are highlighted by a 
blue box. (B) UV–vis spectra of mitoNEET, NAF-1 and Miner2. Note the similarities of the peak 
positions in the visible region which are ligand to metal charge transfer bands reflecting the 
presence of the same type of Fe–S clusters and the similarity of their coordinations (34). 
 
1.4. Structure and biochemical properties of mitoNEET 
The whole length of human mitoNEET is 108 amino acid residues. The first 32 residues 
serve as the hydrophobic lipid anchor, and the rest residues forming the major soluble part facing 
plasma. The soluble part has two major domains, a hydrophilic β-cap structure at top, and a helix 
enriched domain cradling [2Fe-2S] clusters close to the mitochondrial outer membrane (Figure 
1.4). The [2Fe-2S] is buried in hydrophobic core and coordinated with Cys-72, Cys-74, Cys83, 
and His-87 (15). Two major binding sites of type II diabetes drugs pioglitazone has been 
identified.  Lys-42 and Ala-43 from chain 1 and Met-44, Leu-47, Arg-76, His-90, and Thr-94 
from chain 2 forms site 1, and His-48, Ile-49, Trp-75, Arg-76, Ser-77, and Lys-78 from chain 1 
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forms site 2 (49). In our studies, we have also identified a unique FMN binding site which is 
different from, but overlaps with, site 1 and site 2 of mitoNEET (26).  
The redox midpoint potential of the mitoNEET [2Fe-2S] cluster is 0 mV at pH 7, which 
is 300 mV higher than the 4-Cys mutant [2Fe-2S] (H87C) in mitoNEET.  Previous studies have 
proven that the reduced [2Fe-2S] could be oxidized by hydrogen oxide, and the oxidized [2Fe-
2S] could be reduced by biological thiols, including reduced glutathione, L-cysteine or N-acetyl-
L-cysteine, and dithiothreitol (ref). E. coli thioredoxin/thioredoxin reductase system, and 
NADPH dependent human glutathione reductase could also reduce the mitoNEET ISC in (ref). 
Pioglitazone could block the mitoNEET [2Fe-2S] cluster from reduction by biological thiols (24-
26). Another function of pioglitazone is that it may stabilize the [2Fe-2S] cluster in mitoNEET 
(15).  
1.5 Iron-Sulfur cluster protein is the sensor of nitric oxide 
Nitric oxide (NO) is a hydrophobic molecule that can easily penetrate the cell membrane. 
The highly reactive NO can then react with ROS, thiols, etc. and generate S-nitrosothiols, 
nitrogen dioxide, peroxynitrite, dinitrogen trioxide, and nitrite (50). This feature explains why 
the immune system of higher animals uses NO as cytotoxin in the first line of defense against the 
invading pathogens. NO also serves as a key signaling molecule in the muscular and nervous 
system of higher animals (51-54).  
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Figure.1.4 Overall structural organization and domain topology of dimeric mitoNEET. 
 (A Upper) The backbone tracing of each protomer colored in green and magenta, respectively, 
together with the 2F o − F c electron density (gray) map contoured at 1.5σ. The protomers pack 
in a parallel fashion with each protomer harboring a 2Fe–2S cluster, depicted as yellow (sulfur) 
and red (iron) spheres; N and C termini are indicated. (Lower) The box shows an expanded view 
of one 2Fe–2S cluster (rotated ≈90° from upper view) and ligands and the corresponding 
2F o − F celectron density (gray) map contoured at 2.0σ. (B) Ribbon diagram highlighting the 
two domains of the mitoNEET dimer. A six-stranded β-sandwich forms the intertwined β-cap 
domain and a larger cluster-binding domain carries two 2Fe–2S clusters. (C) A topology diagram 
highlighting the organization of the secondary structural units (numbered) illustrates the strand 
swap between protomers. (D) Coded segments contributing to each domain are highlighted on 
the primary sequence and block diagram. Protomer sequences within the cluster-binding domain 
are colored in purple and dark green, and the sequences corresponding to the β-cap domain are 
given in pink and light green, respectively. The amino acid sequence of the resolved amino acid 
strand is shown in the box with the cluster and cap regions colored as for protomer A; the 
numbers indicate the first (Lys-42) and last (Lys-106) resolved amino acid. The ligands to the 
2Fe–2S cluster shown in the expanded boxed view in A are indicated in bold and highlighted in 
gray. The 2Fe–2S binding cradle is located sequentially between two partial β-cap domains. 
Rendered with Pymol (15). 
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There are a serious of ISC proteins, mainly transcriptional regulators, in E. coli that could 
sense NO and adapt the metabolism of the cells to this stress, including MetR, IscR, Fur, FNR, 
and SoxR (55-59). The NO molecule interacts with the iron-sulfur cluster in proteins and results 
in disruption of the cluster and formation of dinitrosyl iron complexes (DNICs) (60). 
(Figure.1.5.)  The NO-modified sensor can then regulate downstream gene transcription (61-63). 
The DINCs in proteins can be repaired by re-assembly of new iron-sulfur clusters (59) (64). For 
example, the [2Fe-2S] cluster of SoxR remains reduced in vivo under normal condition. Upon 
NO stress, the SoxR ISC interacts with NO, and produces SoxR containing dinitrosyl iron 
complex (DNIC) which is active to stimulate the gene expression in cells (65). 
  
 
 
 
Figure. 1.5  Scheme of dinitrosyl iron complexes (DNICs) formation and reparation. 
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 (A) Nitric Oxide could disrupt the [Fe-S] or binds with non-heme iron in cell to form the DNIC. 
(B) Mechanisms in cell to repair the DNIC.   
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CHAPTER 2. ELECTRON TRANSFER ACTIVITY OF MITONEET 
2.1 Introduction 
Pioglitazone is a drug prescribed for the treatment of type II diabetes (1). In addition to 
acting on the peroxisome proliferator activated receptor gamma (PPAR) which regulates 
expression of the genes related to insulin sensitivity (2), pioglitazone also has a rapid 
pharmacological effect on energy metabolism in mitochondria (3). Search of the 
pioglitazonebinding targets revealed a new protein, mitoNEET, which localizes in the 
mitochondrial outer membrane (4). In mice, deletion of mitoNEET results in decrease of 
oxidative phosphorylation capacity in mitochondria by about 30% (5). On the other hand, 
overexpression of mitoNEET enhances lipid storage and decreases oxidative damage in 
adipocytes (6,7), and inhibits ferroptosis in human hepatocellular carcinoma cells (8). In beta 
cells, increased expression of mitoNEET leads to hyperglycemia and glucose intolerance (9). In 
spinal neurons, microRNA-127 has been shown to specifically target expression of mitoNEET, 
and depletion of mitoNEET results in neuronal loss and apoptosis (10). In breast cancer cells, 
mitoNEET is highly expressed, and depletion of mitoNEET inhibits cancer cell proliferation 
(11,12). It has thus been postulated that mitoNEET is a key regulator of energy metabolism in 
mitochondria (13), and an attractive chemotherapeutic target for treating the mitochondria-
related human diseases (14-17). 
 
 
This chapter previously published as: Wang, Yiming, Aaron P. Landry, and Huangen Ding. "The 
mitochondrial outer membrane protein mitoNEET is a redox enzyme catalyzing electron transfer 
from FMNH2 to oxygen or ubiquinone." Journal of Biological Chemistry 292.24 (2017): 10061-
10067. 
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Crystallographic studies have shown that mitoNEET is a homodimer with each monomer 
hosting a [2Fe-2S] cluster via an unusual ligand arrangement of three cysteine and one histidine 
residues in its C-terminal cytosolic domain (18- 21). The N-terminus of mitoNEET has a 
transmembrane -helix which anchors the protein to the mitochondrial outer membrane (4). 
However, the mechanism by which mitoNEET regulates energy metabolism in mitochondria still 
remains elusive. One hypothesis stated that mitoNEET may transfer its [2Fe-2S] clusters to apo-
proteins such as apo-ferredoxin (22), the iron regulatory protein-1 (IRP-1) (23), or anamorsin, a 
protein required for iron-sulfur cluster assembly in cytosol (24). Because mitochondria are the 
primary sites for iron-sulfur cluster biogenesis in cells (25), it is tempting to propose that 
mitoNEET is a carrier transporting the clusters assembled in mitochondria to target proteins in 
cytosol (22-24). However, the observed cluster transfer occurs only when the mitoNEET [2Fe-
2S] clusters are oxidized (22,23), and the mitoNEET [2Fe-2S] clusters are mostly in a reduced 
state in cells under normal physiological conditions (26-29). Thus, the exact role of mitoNEET in 
iron-sulfur cluster biogenesis has yet to be further defined. An alternative hypothesis was that 
mitoNEET may regulate mitochondrial functions via proteinprotein interactions. This hypothesis 
was based on the observations that mitoNEET interacts with mitochondrial proteins including the 
Parkinson's disease associated protein Parkin (9), the mitochondrial outer membrane import 
complex protein 1 (MTX1) (30), glutathione reductase (28), and glutamate dehydrogenase 1 
(31). Nevertheless, no direct evidence is available suggesting that the function of mitochondrial 
proteins are regulated by mitoNEET. 
In previous studies, we have found that human mitoNEET has a specific interaction with 
the reduced flavin mononucleotide (FMNH2), and that FMNH2 can rapidly reduce the 
mitoNEET [2Fe-2S] clusters (29). Here, we report that the reduced mitoNEET [2Fe-2S] clusters 
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can be oxidized by oxygen or ubiquinone-2. Compared with oxygen, ubiquinone-2 appears to be 
more efficient in oxidizing the mitoNEET [2Fe-2S] clusters, indicating that ubiquinone may act 
as a native electron acceptor of the reduced mitoNEET [2Fe-2S] clusters in mitochondria. In the 
presence of flavin reductase which reduces FMN to FMNH2 using NADH as the electron donor, 
mitoNEET mediates oxidation of NADH with a concomitant reduction of oxygen or ubiquinone-
2. Furthermore, pioglitazone can effectively inhibit the electron transfer activity of mitoNEET by 
forming a unique complex with mitoNEET and FMNH2. The results led us to propose that 
mitoNEET is a redox enzyme that may promote oxidation of NADH to enhance glycolysis in 
cytosol, and that pioglitazone may regulate energy metabolism in mitochondria by inhibiting the 
electron transfer activity of mitoNEET. 
 
2.2   Materials and Methods 
Protein preparation 
Human mitochondrial outer membrane protein mitoNEET33–108 (containing residues 
33-108) was purified as described in (28). Escherichia coli flavin reductase (Fre) was prepared 
using an E. coli strain hosting an expression plasmid encoding Fre from the ASKA library (46). 
Both mitoNEET and Fre were overproduced in E. coli cells, and purified using Ni-agarose 
columns, followed by passing through a High-Trap Desalting column. The purity of purified 
proteins was greater than 95% as judged by electrophoresis analysis on a 15% polyacrylamide 
gel containing SDS followed by staining with Coomassie Blue. The protein concentrations of 
mitoNEET and E. coli Fre were measured at 280 nm using the molar extinction coefficients of 
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8.6 and 26.4 mM-1 cm-1, respectively. The molar extinction coefficients were calculated based 
on the protein primary sequence.  
Redox state of the mitoNEET [2Fe-2S] clusters 
Reduction and oxidation of the mitoNEET [2Fe-2S] clusters in incubation solutions were 
monitored using a Beckman DU640 UV-visible absorption spectrometer equipped with a 
temperature controller. Oxidized mitoNEET [2Fe-2S] clusters have two major absorption peaks 
at 455 nm and 540 nm, while reduced mitoNEET [2Fe-2S] clusters have the absorption peaks at 
420 nm and 540 nm (29). The redox state of the mitoNEET [2Fe-2S] clusters was further 
determined by EPR measurements. Oxidation of NADH in the incubation solution was 
monitored at 340 nm after subtracting the basal absorption of proteins the incubation solution. 
Anaerobic conditions were achieved by purging the incubation solutions with pure argon gas for 
15 min in a sealed vial.  
EPR measurements 
The X-band Electron Paramagnetic Resonance (EPR) spectra were recorded using a 
Bruker model ESR-300 spectrometer equipped with an Oxford Instruments 910 continuous flow 
cryostat. Routine EPR conditions were: microwave frequency, 9.47 GHz; microwave power, 
10.0 mW; modulation frequency, 100 kHz; modulation amplitude, 1.2 mT; temperature, 30 K; 
receiver gain, 2x105.  
Chemicals 
NADH, NADPH, Isopropyl-β-D-1- thiogalactopyranoside, kanamycin, and ampicillin 
were purchased from Research Product International co. FMN, FAD, ubiquinone-2, pioglitazone, 
NL-1, and other chemicals were purchased from Sigma co. The molar extinction coefficients of 
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6.2 mM-1 cm-1 at 340 nm, 12.5 mM1 cm-1 at 445 nm, and 11.3 mM-1 cm-1 at 450 nm were 
used for measuring the concentration of NADH/NADPH, FMN and FAD, respectively (43). The 
molar extinction coefficient of 14.9 mM1 cm-1 at 278 nm was used for ubiquinone-2. 
 
2.3 Results 
Reduction of the mitoNEET [2Fe-2S] clusters under Anaerobic and Aerobic conditions 
Previous studies have shown that human mitoNEET has a specific interaction with 
FMNH2, and that FMNH2 can quickly reduce the mitoNEET [2Fe-2S] clusters (29). As oxygen 
would be present in mitochondria, we asked whether oxygen will have any effects on the 
FMNH2-mediated reduction of the mitoNEET [2Fe-2S] clusters.  
To test this idea, human mitoNEET was preincubated with FMN and NADH under 
anaerobic or aerobic conditions. The reaction was initiated by adding a catalytic amount of E. 
coli flavin reductase (32) to reduce FMN using NADH as the electron donor (29). Figure 2.1A 
shows that under anaerobic conditions, the oxidized mitoNEET [2Fe-2S] clusters (indicated by 
the absorption peaks at 455 nm and 540 nm (27)) were quickly reduced upon addition of flavin 
reductase, as reported previously (29). About 10 M NADH was oxidized when 10 M 
mitoNEET [2Fe-2S] clusters were reduced in the incubation solution under anaerobic conditions 
(Figure 2.1C). Under aerobic conditions, the mitoNEET [2Fe-2S] clusters were also fully 
reduced after addition of flavin reductase (Figure 2.1B). However, NADH was continuously 
oxidized even after the mitoNEET [2Fe-2S] clusters were fully reduced (Figure 2.1C). The 
observed oxidation of NADH was mitoNEET-dependent, as only a very small amount of NADH 
was oxidized in the same incubation solution without mitoNEET under aerobic conditions 
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(Figure 2.1D). Thus, mitoNEET is able to promote oxidation of NADH in the presence of flavin 
reductase and FMN under aerobic conditions. 
 
Figure 2.1 Reduction of the mitoNEET [2Fe-2S] clusters by FMNH2 under aerobic and 
anaerobic conditions.  
MitoNEET (containing 10 M [2Fe-2S] clusters) was incubated with FMN (0.1 M) and NADH 
(fig. caption cont'd.) 
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 (60 M) under anaerobic (A) and aerobic (B) conditions. Flavin reductase (Fre) (0.1 M) was 
then added to the solutions to initiate the reaction. UV-visible absorption spectra were taken 
every 80 seconds after addition of Fre for 560 seconds. Absorption peaks at 455 nm and 540 nm 
represent the oxidized mitoNEET [2Fe-2S] clusters. C), time courses of NADH oxidation in the 
incubation solutions containing mitoNEET, Fre and FMN under anaerobic (A) (closed circles) or 
aerobic (B) (open circles) conditions. The amount of NADH in the incubation solutions was 
measured from the absorption peak at 340 nm after subtracting the absorption of proteins in the 
incubation solutions. D), same as in B) except no mitoNEET was included. The data were 
representatives of three independent experiments. 
 
The reduced mitoNEET [2Fe-2S] clusters are oxidized by oxygen under aerobic conditions 
In the presence of flavin reductase, FMN and excess NADH, the mitoNEET [2Fe-2S] 
clusters were fully reduced under aerobic conditions (Figure 2.1B). One explanation could be 
that the reduced mitoNEET [2Fe-2S] clusters are oxidized by oxygen and rapidly re-reduced by 
FMNH2/NADH/flavin reductase under aerobic conditions. To test this idea, mitoNEET was 
incubated with a limited amount of NADH and FMN under aerobic conditions. As shown in 
Figure 2.2, the mitoNEET [2Fe-2S] clusters were fully reduced upon addition of a catalytic 
amount of flavin reductase. However, when NADH in the incubation solution was completely 
oxidized, the reduced mitoNEET [2Fe-2S] clusters were gradually re-oxidized under aerobic 
conditions, demonstrating that the reduced mitoNEET [2Fe2S] clusters are indeed oxidized by 
oxygen under aerobic conditions.  
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Figure 2.2 Oxidation kinetics of the reduced mitoNEET [2Fe-2S] clusters by oxygen.  
MitoNEET (containing 10 M [2Fe-2S] clusters) was incubated with FMN (0.1 M) and NADH 
(20 M) under aerobic conditions. Flavin reductase (Fre) (0.1 M) was then added to the 
incubation solution to initiate the reaction. The amount of NADH in the incubation solution was 
measured from the absorption peak at 340 nm. The amount of the reduced mitoNEET [2Fe-2S] 
clusters was measured from the different absorption at the absorption peaks of 455 nm and 420 
nm. The amounts of NADH and the reduced mitoNEET [2Fe-2S] clusters in the incubation 
solution were plotted as a function of incubation time. The data were representatives of three 
independent experiments. 
 
 
The reduced mitoNEET [2Fe-2S] clusters can also be oxidized by ubiquinone 
2 under anaerobic conditions–In mitochondria, the NADH-ubiquinone oxidoreductase 
(complex I) oxidizes NADH and reduces ubiquinone via FMN and a chain of iron-sulfur clusters 
(33). Ubiquinone is a key electron transport component in respiratory chain (34), and is present 
in both mitochondrial inner and outer membranes (35). As mitoNEET is a mitochondrial outer 
membrane protein (4), and the [2Fe-2S] clusters in mitoNEET are positioned close to the 
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membrane (18-21), we postulated that the reduced mitoNEET [2Fe-2S] clusters may also reduce 
ubiquinone in the mitochondrial outer membrane.  
In the experiments, the mitoNEET [2Fe-2S] clusters were pre-reduced with flavin 
reductase, FMN, and an excess amount of NADH under anaerobic conditions. Ubiquinone-2, a 
ubiquinone-10 analog, was then injected to the incubation solution anaerobically using a gastight 
syringe. Figure 2.3 shows that the reduced mitoNEET [2Fe-2S] clusters were immediately 
oxidized upon injection of ubiquinone-2 under anaerobic conditions. In control, injection of 
degassed water had no effect on the reduced mitoNEET [2Fe-2S] clusters. After further 
incubation, the ubiquinone-2- oxidized mitoNEET [2Fe-2S] clusters were fully re-reduced in the 
incubation solution (Figure 2.3A), suggesting that oxidation of the mitoNEET [2Fe2S] clusters 
by ubiquinone-2 is reversible. 
We also tested whether the reduced mitoNEET [2Fe-2S] clusters could be oxidized by 
other oxidants. In the experiments, the mitoNEET [2Fe-2S] clusters were pre-reduced with flavin 
reductase, FMN, and an excess amount of NADH under anaerobic conditions, followed by 
injection of oxidants anaerobically. We found that DCIP (dichlorophenolindophenol), 
K3Fe(CN)6 or menadione could all quickly oxidize the reduced mitoNEET [2Fe-2S] clusters, 
suggesting that the reduced mitoNEET [2Fe-2S] clusters may also be oxidized by other oxidants 
in cytosol. Oxidation of the mitoNEET [2Fe-2S] clusters by DCIP or K3Fe(CN)6 was very 
similar to that of ubiquinone-2. However, menadione appeared to be less active to oxidize the 
mitoNEET [2Fe-2S] clusters under the experimental conditions. Since ubiquinone is a 
physiological oxidant and is in the vicinity of the mitoNEET [2Fe-2S] clusters in mitochondria, 
we propose that ubiquinone could be a native electron acceptor for the reduced mitoNEET [2Fe-
2S] clusters in mitochondria. 
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Figure 2.3 Oxidation of the reduced mitoNEET [2Fe-2S] clusters by ubiquinone-2 under 
anaerobic condition.  
A), oxidation of the reduced mitoNEET [2Fe-2S] clusters by ubiquinone-2 under anaerobic 
conditions. MitoNEET (containing 10 M [2Fe-2S] clusters) was reduced with FMN (0.1 M) 
and NADH (50 M) and flavin reductase (0.1 M) under anaerobic conditions. Ubiquinone-2 
(Q2) (20 M) was injected into the incubation solution anaerobically as indicated. The reduced 
mitoNEET [2Fe-2S] clusters were measured from the different absorption at the absorption 
peaks of 455 nm and 420 nm, and plotted as function of the incubation time. B), UV-visible 
absorption spectra of mitoNEET. Spectra were taken before (spectrum 1) and after (spectrum 2) 
addition of NADH (50 M). Spectrum 3, right after anaerobic addition of ubiquinone-2 (20 M). 
The experiments were repeated three times. Similar results were obtained. 
 
 
Oxidation of the reduced mitoNEET [2Fe-2S] clusters by ubiquinone-2 under aerobic 
conditions 
Compared with oxygen (Figure 2.2), ubiquinone-2 is much more efficient in oxidizing 
the reduced mitoNEET [2Fe-2S] clusters (Figure 2.3A). To further explore the reactivity of the 
reduced mitoNEET [2Fe-2S] clusters with oxygen and ubiquinone-2, we incubated mitoNEET 
with FMN, NADH and ubiquinone-2 under aerobic conditions. Figure 2.4A shows that NADH 
was continuously oxidized after flavin reductase was added to the incubation solution. The 
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observed NADH oxidation was mitoNEET-dependent, as only a very small amount of NADH 
was oxidized in the incubation solution without mitoNEET under aerobic conditions (Figure 
2.4B). Importantly, despite oxidation of NADH in the incubation solution containing 
ubiquinone-2, the mitoNEET [2Fe-2S] clusters remained oxidized during the incubation process 
(Figure 2.4A). This result indicated that the reduced mitoNEET [2Fe-2S] clusters might be 
rapidly oxidized by ubiquinone2 which subsequently transferred electron to oxygen under 
aerobic conditions. Indeed, when the incubation solution in Figure 2.4A was purged with pure 
argon gas to remove oxygen, the mitoNEET [2Fe-2S] clusters were re-reduced upon addition of 
NADH (Figure 2.4C and D). Thus, the results further suggest that ubiquinone in mitochondria 
may act as an intrinsic electron acceptor for the mitoNEET [2Fe-2S] clusters under anaerobic or 
aerobic conditions. 
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Figure 2.4 Oxidation of the reduced mitoNEET [2Fe-2S] clusters by ubiquinone-2 under aerobic 
condition. 
A), mitoNEET (containing 10 M [2Fe-2S] clusters) was pre-incubated with FMN (0.1 M), 
NADH (50 M), and ubiquinone-2 (20 M) under aerobic conditions. UV-visible absorption 
spectra were taken every 40 seconds after addition of Fre (0.1 M) for 320 seconds. The amount 
of NADH in the incubation solution was measured from the absorption peak at 340 nm. B), same 
as A), except mitoNEET was not included in the incubation solution. C), the incubation solution 
in A) was purged with pure argon gas for 10 min, followed by injection of NADH (50 M) 
(fig. caption cont'd.) 
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 anaerobically. UV-visible absorption spectra were taken every 40 seconds for 320 seconds. D), 
redox transition of the mitoNEET [2Fe-2S] clusters under aerobic and anaerobic conditions. The 
data were from panels A) and C). The amount of the reduced mitoNEET [2Fe-2S] clusters was 
measured from the different absorption at the peaks of 455 nm and 420 nm in each spectrum. 
The data were representatives of three independent experiments. 
 
A pioglitazone analog NL-1 inhibits the electron transfer activity of mitoNEET 
MitoNEET was identified as a target of the type II diabetes drug pioglitazone (1).  
However, pioglitazone has a very low solubility in water (<1 mg/ml), making it difficult to 
characterize its biochemical activity (28). A new pioglitazone analog, NL-1 or 5-(3,5-di-tert-
butyl-4hydroxybenzyl)-4-hydroxythiazol-2(5H)-one, was designed and synthesized by 
Geldenhuys, et al. (36).  NL-1 has been improved for its solubility in water and binding 
specificity to mitoNEET.  It has similar pharmacological activities as pioglitazone to decrease 
the maximal respiration rate of mitochondria by 45%, reduce the production of reactive oxygen 
species (36), and improve the cell survival of cardiac stem cells during oxidative stress (37).  
Here, we explored the effect of NL-1 on the electron transfer activity of mitoNEET.  In 
the experiments, mitoNEET was pre-incubated with increasing concentrations of NL-1 under 
aerobic conditions, followed by addition of flavin reductase and FMN.  The reaction was 
initiated by adding NADH.  The amounts of the reduced mitoNEET [2Fe-2S] clusters in the 
incubation solutions were monitored spectroscopically, and plotted as a function of incubation 
time.   Figure 2.5 shows that as the concentration of NL-1 increased, the reduction of the 
mitoNEET [2Fe-2S] clusters in the incubation solution gradually decreased.  At 250 µM NL-1, 
the reduction of the mitoNEET [2Fe-2S] clusters (10 µM) in the incubation solution was 
inhibited by about 70%, indicating that NL-1 can effectively block the electron transfer activity 
of mitoNEET.  
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Figure 2.5 Inhibition of the electron transfer activity of mitoNEET by the pioglitazone analog 
NL-1. 
 MitoNEET (containing 10 M [2Fe-2S] clusters) was pre-incubated with increasing 
concentrations of NL1 (from 0 to 250 M) at room temperature for 30 min under aerobic 
conditions, followed by addition of FMN (0.1 M) and flavin reductase (0.1 M). NADH (50 
M) was then added to the incubation solutions to initiate the reaction. The amount of the 
reduced mitoNEET [2Fe-2S] clusters in the incubation solutions was measured from the different 
absorption at the absorption peaks of 455 nm and 420 nm and plotted as function of the reaction 
time after injection of NADH. The data are representatives from three independent experiments. 
 
 
Pioglitazone/NL-1 and FMNH2 forms a unique complex with the reduced mitoNEET [2Fe-
2S] cluster 
To further assess the effects of pioglitazone and its analog NL-1 on the electron transfer 
activity of mitoNEET, mitoNEET was incubated with FMN, pioglitazone, NL-1, or the 
combinations at room temperature for one hour under aerobic conditions. The samples were then 
reduced with sodium dithionite for the electron paramagnetic resonance (EPR) measurements of 
the reduced mitoNEET [2Fe-2S] clusters. Figure 2.6A shows that incubation with FMNH2 
results in a small EPR signal at g = 1.85 of the reduced mitoNEET [2Fe-2S] clusters (spectrum 
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2), as reported previously (29). However, unlike FMNH2, incubation with pioglitazone (4) 
(spectrum 3) or NL-1 (36) (spectrum 4) did not change the EPR spectrum of the reduced 
mitoNEET [2Fe-2S] clusters. Nevertheless, incubation of mitoNEET with FMNH2 and 
pioglitazone completely shifted the typical EPR spectrum at g = 1.94 of the reduced mitoNEET 
[2Fe-2S] clusters to a new EPR spectrum with g = 1.85 (spectrum 5). Same result was also 
observed when mitoNEET was incubated with FMNH2 and NL-1 (spectrum 6). A small EPR 
signal at g = 1.86 of the reduced mitoNEET [2Fe-2S] clusters was previously noticed (38). 
Although the interpretation of the EPR signal at g = 1.85 remains elusive, the dramatic change of 
the EPR spectrum suggests that FMNH2 and pioglitazone/NL-1 may have a close interaction 
with the reduced [2Fe-2S] clusters in mitoNEET, or that binding of FMNH2 and 
pioglitazone/NL-1 may result in conformational changes that alter the structural orientation of 
the cluster ligands in mitoNEET.  
MitoNEET was further incubated with a fixed concentration of FMN and increasing 
concentrations of NL-1 at room temperature for one hour under aerobic conditions, followed by 
reduction with sodium dithionite. Figure 2.6B shows that as the concentration of NL-1 increased, 
the EPR signal at g = 1.85 also gradually increased. About 200 M NL-1 was sufficient to 
change the EPR spectrum of the g = 1.94 to that of the g = 1.85 of the reduced mitoNEET [2Fe-
2S] clusters. The results suggested that FMNH2 and pioglitazone/NL-1 have a synergistic effect 
on the reduced mitoNEET [2Fe-2S] clusters. 
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Figure 2.6 Synergistic effect of FMNH2 and pioglitazone/NL-1 on the reduced mitoNEET [2Fe-
2S] clusters.  
A), EPR spectra of the reduced mitoNEET [2Fe-2S] clusters. MitoNEET (containing 20 M 
[2Fe-2S] clusters) (spectrum 1) was incubated with FMN (50 M) (spectrum 2), pioglitazone 
(Pio) (500 M) (spectrum 3), NL-1 (200 M) (spectrum 4), FMN + pioglitazone (Pio) (spectrum 
5), FMN + NL-1 (spectrum 6) at room temperature for 60 minutes. After incubation, samples 
were reduced with freshly prepared sodium dithionite (4 mM), transferred to EPR tubes, and 
immediately frozen in liquid nitrogen for EPR measurements. B), titration of NL-1. MitoNEET 
(containing 20 M [2Fe-2S] clusters) was incubated with FMN (50 M) and increasing 
concentrations of NL-1 (0 to 200 M) (spectra 1-5) at room temperature for 60 min. After 
incubation, samples were reduced with freshly prepared sodium dithionite (4 mM), transferred to 
EPR tubes, and immediately frozen in liquid nitrogen for EPR measurements. The data were 
representatives of three independent experiments. 
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2.4 Discussion  
MitoNEET is a founding member of a small family of proteins that contain a CDGSH 
(CysAsp-Gly-Ser-His) motif (39,40). Although it has been reported that mitoNEET is a key 
regulator of energy metabolism in mitochondria (13), the underlying mechanism has not been 
fully understood. Several research groups proposed that mitoNEET may transfer its [2Fe-2S] 
clusters for maturation of iron-sulfur proteins in cytosol (22- 24). Others suggested that 
mitoNEET may regulate mitochondrial functions via specific protein-protein interactions (9). 
Here, we report that mitoNEET is a novel redox enzyme that transfers electron from FMNH2 to 
oxygen or ubiquinone in the mitochondrial outer membrane via its [2Fe-2S] clusters. In this 
process, FMNH2, which may be reduced by flavin reductase (41) and NADH in cytosol, binds to 
mitoNEET and reduces the [2Fe-2S] clusters in mitoNEET (29). The reduced mitoNEET [2Fe-
2S] clusters are readily oxidized by oxygen or ubiquinone (Figure 2.7). Together with flavin 
reductase (41) and FMN, mitoNEET may effectively promote oxidation of NADH in cytosol 
with a concomitant reduction of oxygen or ubiquinone in the mitochondrial outer membrane.  
The intracellular concentration of FMN in human cells is in nanomolar range (42). Here 
we find that 100 nM FMN is sufficient to reduce 10 M mitoNEET [2Fe-2S] clusters in the 
presence of flavin reductase and NADH in less than 2 min (Figure 2.1), indicating that FMN may 
act as an electron shuttle reducing the mitoNEET [2Fe-2S] clusters (29). In cytosol, FMN is 
reduced to FMNH2 by flavin reductase (41) using NADH as the electron donor. Because 
glycolysis will produce NADH which must be oxidized in order to sustain glycolysis activity 
(43), mitoNEET may enhance glycolysis by promoting oxidation of NADH in cytosol (Figure 
2.7). In primary and metastatic cancer cells, glycolysis is highly upregulated, resulting in 
increased glucose consumption (44). Interestingly, mitoNEET is also highly expressed in cancer 
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cells and over expression of mitoNEET is essential for cancer cell proliferation (11,12). In this 
context, we propose that overproduced mitoNEET may enhance glycolysis in cytosol by 
promoting oxidation of NADH in cancer cells. Accordingly, when mitoNEET is deleted, 
oxidation of NADH in cytosol could be diminished, leading to decrease of glycolysis in cytosol 
and oxidative phosphorylation in mitochondria. This notion is consistent with the previous report 
showing that deletion of mitoNEET decreases oxidative phosphorylation capacity in 
mitochondria by about 30% (5) and inhibits cancer cell proliferation (11,12). Nevertheless, 
additional experiments are required to elucidate the physiological link between the electron 
transfer activity of mitoNEET and glycolysis in cells.  
Iron-sulfur clusters in proteins are often sensitive to oxygen and reactive oxygen species 
(45). However, the mitoNEET [2Fe-2S] clusters are highly resistant to oxygen and hydrogen 
peroxide (27). In fact, the reduced mitoNEET [2Fe-2S] clusters can be oxidized by oxygen 
without disruption of the cluster (Figure 2.2). Importantly, compared with oxygen, ubiquinone2 
is more efficient in oxidizing the reduced mitoNEET [2Fe-2S] clusters (Figures 2.3 and 2.4). 
Since mitoNEET is a mitochondrial outer membrane protein (4), and the [2Fe-2S] clusters in 
mitoNEET are positioned close to the membrane (18-21), we propose that ubiquinone could be 
an intrinsic electron acceptor for the reduced mitoNEET [2Fe-2S] clusters (Figure 2.7). Upon the 
single-electron reduction by the reduced mitoNEET [2Fe-2S] cluster, ubiquinone is converted to 
semiquinone which may be further reduced to ubihydroquinone, or transfer the electron to 
oxygen to produce superoxide or hydrogen peroxide (34). While other oxidants in cytosol may 
also oxidize the reduced mitoNEET [2Fe-2S] clusters in cytosol, the proposed electron transfer 
path from NADH to ubiquinone catalyzed by the mitoNEET [2Fe-2S] clusters (Figure 2.7) is 
reminiscent of the electron transfer path in complex I in which electrons in NADH are 
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transferred to ubiquinone via FMN and a chain of iron-sulfur clusters (33). The observed 
reduction of oxygen by the mitoNEET [2Fe-2S] clusters may reflect the possible electron 
transfer leak in mitoNEET, as reported in complex I (33). The final products of the electron 
transfer reaction catalyzed by mitoNEET in mitochondria remain to be determined.  
Pioglitazone has two major targets in cells: PPAR that regulates the expression of genes 
involved in insulin sensitivity (2) and mitoNEET (4) that modulates energy metabolism in 
mitochondria (3). It was previously reported that binding of pioglitazone stabilizes the 
mitoNEET [2Fe-2S] clusters (21) and shifts the redox midpoint potential of the [2Fe-2S] clusters 
by about 100 mV (26). Here, we find that pioglitazone and its analog NL-1 (36) can inhibit the 
electron transfer activity of mitoNEET (Figure 2.5) by forming a unique complex with 
mitoNEET and FMNH2 which has an unusual EPR signal at g = 1.85 (Figure 2.6). Based on the 
molecular docking modeling (29,36), FMN and pioglitazone/NL-1 have distinct binding sites but 
with significant overlap in mitoNEET, suggesting that pioglitazone/NL-1 may interfere the 
FMNH2 binding in mitoNEET and inhibit the electron transfer activity of mitoNEET in 
mitochondria. As mitoNEET is proposed as a chemotherapeutic target for treating type II 
diabetes (4), breast cancer (16,17), and neurodegenerative diseases (10), a high-throughput 
screening approach combining the electron transfer activity assay and EPR measurements of 
mitoNEET may help identify new drugs that specifically target the mitoNEET [2Fe-2S] clusters 
in mitochondria. 
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Figure 2.7 A proposed model for the electron transfer of mitoNEET in mitochondria outer 
membrane.  
In cytosol, FMNH2 is reduced by flavin reductase using NADH as the electron donor. FMNH2 
then reduces the mitoNEET [2Fe-2S] clusters which in turn transfer electrons to oxygen or 
ubiquinone in the mitochondrial outer membrane. Together with flavin reductase and FMN, 
mitoNEET promotes NADH oxidation with a concomitant reduction of oxygen or ubiquinone in 
mitochondria. 
 
 
2.5 References  
1. Hippisley-Cox, J., and Coupland, C. (2016) Diabetes treatments and risk of heart failure, 
cardiovascular disease, and all-cause mortality: cohort study in primary care. BMJ 354, 
i3477  
 
2. Wright, M. B., Bortolini, M., Tadayyon, M., and Bopst, M. (2014) Minireview: Challenges 
and opportunities in development of PPAR agonists. Mol. Endocrinol. 28, 1756-1768  
 
3. Feinstein, D. L., Spagnolo, A., Akar, C., Weinberg, G., Murphy, P., Gavrilyuk, V., and 
Russo, C. D. (2005) Receptor-independent actions of PPAR thiazolidinedione agonists: Is 
mitochondrial function the key? Biochem. Pharmacol. 70, 177-188  
 
4. Colca, J. R., McDonald, W. G., Waldon, D. J., Leone, J. W., Lull, J. M., Bannow, C. A., 
Lund, E. T., and Mathews, W. R. (2004) Identification of a novel mitochondrial protein 
("mitoNEET") crosslinked specifically by a thiazolidinedione photoprobe. Am. J. Physiol. 
Endocrinol. Metab. 286, E252-E260  
36 
 
 
5. Wiley, S. E., Murphy, A. N., Ross, S. A., van der Geer, P., and Dixon, J. E. (2007) 
MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates 
oxidative capacity. Proc. Natl. Acad. Sci. U. S. A. 104, 5318-5323  
 
6. Kusminski, C. M., Holland, W. L., Sun, K., Park, J., Spurgin, S. B., Lin, Y., Askew, G. R., 
Simcox, J. A., McClain, D. A., Li, C., and Scherer, P. E. (2012) MitoNEET-driven 
alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that 
preserves insulin sensitivity in obesity. Nat. Med. 18, 1539-1549  
 
7. Kusminski, C. M., Park, J., and Scherer, P. E. (2014) MitoNEET-mediated effects on 
browning of white adipose tissue. Nat. commun. 5, 3962  
 
8. Yuan, H., Li, X., Zhang, X., Kang, R., and Tang, D. (2016) CISD1 inhibits ferroptosis by 
protection against mitochondrial lipid peroxidation. Biochem. Biophys. Res. Commun. 478, 
838-844  
 
9. Kusminski, C. M., Chen, S., Ye, R., Sun, K., Wang, Q. A., Spurgin, S. B., Sanders, P. E., 
Brozinick, J. T., Geldenhuys, W. J., Li, W. H., Unger, R. H., and Scherer, P. E. (2016) 
MitoNEET-Parkin Effects in Pancreatic alpha- and beta-Cells, Cellular Survival, and 
Intrainsular Cross Talk. Diabetes 65, 1534-1555  
 
10. He, Q. Q., Xiong, L. L., Liu, F., He, X., Feng, G. Y., Shang, F. F., Xia, Q. J., Wang, Y. C., 
Qiu, D. L., Luo, C. Z., Liu, J., and Wang, T. H. (2016) MicroRNA-127 targeting of 
mitoNEET inhibits neurite outgrowth, induces cell apoptosis and contributes to 
physiological dysfunction after spinal cord transection. Sci. Rep. 6, 35205  
 
11. Sohn, Y. S., Tamir, S., Song, L., Michaeli, D., Matouk, I., Conlan, A. R., Harir, Y., Holt, 
S. H., Shulaev, V., Paddock, M. L., Hochberg, A., Cabanchick, I. Z., Onuchic, J. N., 
Jennings, P. A., Nechushtai, R., and Mittler, R. (2013) NAF-1 and mitoNEET are central 
to human breast cancer proliferation by maintaining mitochondrial homeostasis and 
promoting tumor growth. Proc. Natl. Acad. Sci. U. S. A. 110, 14676-14681  
 
12. Salem, A. F., Whitaker-Menezes, D., Howell, A., Sotgia, F., and Lisanti, M. P. (2012) 
Mitochondrial biogenesis in epithelial cancer cells promotes breast cancer tumor growth 
and confers autophagy resistance. Cell Cycle 11, 4174-4180  
 
 
13. Tamir, S., Paddock, M. L., Darash-Yahana-Baram, M., Holt, S. H., Sohn, Y. S., Agranat, 
L., Michaeli, D., Stofleth, J. T., Lipper, C. H., Morcos, F., Cabantchik, I. Z., Onuchic, J. 
N., Jennings, P. A., Mittler, R., and Nechushtai, R. (2015) Structure-function analysis of 
NEET proteins uncovers their role as key regulators of iron and ROS homeostasis in health 
and disease. Biochim. Biophys. Acta 1853, 1294-1315  
 
14. Bieganski, R. M., and Yarmush, M. L. (2011) Novel ligands that target the mitochondrial 
membrane protein mitoNEET. J. Mol. Graph. Model. 29, 965-973  
37 
 
 
15. Takahashi, T., Yamamoto, M., Amikura, K., Kato, K., Serizawa, T., Serizawa, K., 
Akazawa, D., Aoki, T., Kawai, K., Ogasawara, E., Hayashi, J., Nakada, K., and Kainoh, 
M. (2015) A novel MitoNEET ligand, TT01001, improves diabetes and ameliorates 
mitochondrial function in db/db mice. J. Pharmacol. Exp. Ther. 352, 338-345  
 
16. Bai, F., Morcos, F., Sohn, Y. S., Darash-Yahana, M., Rezende, C. O., Lipper, C. H., 
Paddock, M. L., Song, L., Luo, Y., Holt, S. H., Tamir, S., Theodorakis, E. A., Jennings, P. 
A., Onuchic, J. N., Mittler, R., and Nechushtai, R. (2015) The Fe-S cluster-containing 
NEET proteins mitoNEET and NAF-1 as chemotherapeutic targets in breast cancer. Proc. 
Natl. Acad. Sci. U. S. A. 112, 3698-3703  
 
17. Geldenhuys, W. J., Yonutas, H. M., Morris, D. L., Sullivan, P. G., Darvesh, A. S., and 
Leeper, T. C. (2016) Identification of small molecules that bind to the mitochondrial 
protein mitoNEET.  
Bioorg. Med. Chem. Lett. 26, 5350-5353  
 
18. Wiley, S. E., Paddock, M. L., Abresch, E. C., Gross, L., van der Geer, P., Nechushtai, R., 
Murphy, A. N., Jennings, P. A., and Dixon, J. E. (2007) The outer mitochondrial 
membrane protein mitoNEET contains a novel redox-active 2Fe-2S cluster. J. Biol. Chem. 
282, 23745-23749  
 
19. Hou, X., Liu, R., Ross, S., Smart, E. J., Zhu, H., and Gong, W. (2007) Crystallographic 
studies of human MitoNEET. J. Biol. Chem. 282, 33242-33246  
 
20. Lin, J., Zhou, T., Ye, K., and Wang, J. (2007) Crystal structure of human mitoNEET 
reveals distinct groups of iron–sulfur proteins. Proc. Natl. Acad. Sci. U. S. A. 104, 14640-
14645  
 
21. Paddock, M. L., Wiley, S. E., Axelrod, H. L., Cohen, A. E., Roy, M., Abresch, E. C., 
Capraro, D., Murphy, A. N., Nechushtai, R., Dixon, J. E., and Jennings, P. A. (2007) 
MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized 
by pioglitazone. Proc. Natl. Acad.  
Sci. U. S. A. 104, 14342-14347  
 
22. Zuris, J. A., Harir, Y., Conlan, A. R., Shvartsman, M., Michaeli, D., Tamir, S., Paddock, 
M. L., Onuchic, J. N., Mittler, R., Cabantchik, Z. I., Jennings, P. A., and Nechushtai, R. 
(2011) Facile transfer of [2Fe-2S] clusters from the diabetes drug target mitoNEET to an 
apo-acceptor protein. Proc. Natl. Acad. Sci. U. S. A. 108, 13047-13052  
 
23. Golinelli-Cohen, M. P., Lescop, E., Mons, C., Goncalves, S., Clemancey, M., Santolini, 
J., Guittet, E., Blondin, G., Latour, J. M., and Bouton, C. (2016) Redox Control of the 
Human Iron-Sulfur Repair Protein MitoNEET Activity via Its Iron-Sulfur Cluster. J. Biol. 
Chem. 291, 7583-7593  
 
38 
 
24. 24. Lipper, C. H., Paddock, M. L., Onuchic, J. N., Mittler, R., Nechushtai, R., and Jennings, 
P. A. (2015) Cancer-Related NEET Proteins Transfer 2Fe-2S Clusters to Anamorsin, a 
Protein Required for Cytosolic Iron-Sulfur Cluster Biogenesis. PLoS One 10, e0139699  
 
25. Paul, V. D., and Lill, R. (2015) Biogenesis of cytosolic and nuclear iron-sulfur proteins 
and their role in genome stability. Biochim. Biophys. Acta 1853, 1528-1539  
 
26. Bak, D. W., Zuris, J. A., Paddock, M. L., Jennings, P. A., and Elliott, S. J. (2009) Redox 
characterization of the FeS protein MitoNEET and impact of thiazolidinedione drug 
binding. Biochemistry 48, 10193-10195  
 
27. Landry, A. P., and Ding, H. (2014) Redox Control of Human Mitochondrial Outer 
Membrane Protein MitoNEET [2Fe-2S] Clusters by Biological Thiols and Hydrogen 
Peroxide. J. Biol. Chem. 289, 4307-4315  
 
28. Landry, A. P., Cheng, Z., and Ding, H. (2015) Reduction of mitochondrial protein 
mitoNEET [2Fe2S] clusters by human glutathione reductase. Free Radic. Biol. Med. 81, 
119-127  
 
29. Landry, A. P., Wang, Y., Cheng, Z., Crochet, R. B., Lee, Y. H., and Ding, H. (2017) Flavin 
nucleotides act as electron shuttles mediating reduction of the [2Fe-2S] clusters in 
mitochondrial outer membrane protein mitoNEET. Free Radic. Biol. Med. 102, 240-247  
 
30. Havugimana, P. C., Hart, G. T., Nepusz, T., Yang, H., Turinsky, A. L., Li, Z., Wang, P. I., 
Boutz, D. R., Fong, V., Phanse, S., Babu, M., Craig, S. A., Hu, P., Wan, C., Vlasblom, J., 
Dar, V. U., Bezginov, A., Clark, G. W., Wu, G. C., Wodak, S. J., Tillier, E. R., Paccanaro, 
A., Marcotte, E. M., and Emili, A. (2012) A census of human soluble protein complexes. 
Cell 150, 1068-1081  
 
31. Roberts, M. E., Crail, J. P., Laffoon, M. M., Fernandez, W. G., Menze, M. A., and Konkle, 
M. E. (2013) Identification of disulfide bond formation between MitoNEET and glutamate 
dehydrogenase 1. Biochemistry 52, 8969-8971  
 
32. Ingelman, M., Ramaswamy, S., Niviere, V., Fontecave, M., and Eklund, H. (1999) Crystal 
structure of NAD(P)H:flavin oxidoreductase from Escherichia coli. Biochemistry 38, 
7040-7049.  
 
33. Baradaran, R., Berrisford, J. M., Minhas, G. S., and Sazanov, L. A. (2013) Crystal structure 
of the entire respiratory complex I. Nature 494, 443-448  
 
34. Song, Y., and Buettner, G. R. (2010) Thermodynamic and kinetic considerations for the 
reaction of semiquinone radicals to form superoxide and hydrogen peroxide. Free Radic. 
Biol. Med. 49, 919-962  
 
39 
 
35. Lapointe, J., Wang, Y., Bigras, E., and Hekimi, S. (2012) The submitochondrial 
distribution of ubiquinone affects respiration in long-lived Mclk1+/- mice. J. Cell Biol. 
199, 215-224  
 
36. Geldenhuys, W. J., Funk, M. O., Barnes, K. F., and Carroll, R. T. (2010) Structure-based 
design of a thiazolidinedione which targets the mitochondrial protein mitoNEET. Bioorg. 
Med. Chem. Lett. 20, 819-823  
 
37. Logan, S. J., Yin, L., Geldenhuys, W. J., Enrick, M. K., Stevanov, K. M., Carroll, R. T., 
Ohanyan, V. A., Kolz, C. L., and Chilian, W. M. (2015) Novel thiazolidinedione 
mitoNEET ligand-1 acutely improves cardiac stem cell survival under oxidative stress. 
Basic Res. Cardiol. 110, 19  
38. Iwasaki, T., Samoilova, R. I., Kounosu, A., Ohmori, D., and Dikanov, S. A. (2009) 
Continuouswave and pulsed EPR characterization of the [2Fe-2S](Cys)3(His)1 cluster in 
rat MitoNEET. J. Am. Chem. Soc. 131, 13659-13667  
 
39. Lin, J., Zhang, L., Lai, S., and Ye, K. (2011) Structure and molecular evolution of CDGSH 
ironsulfur domains. PLoS One 6, e24790  
 
40. Inupakutika, M. A., Sengupta, S., Nechushtai, R., Jennings, P. A., Onuchic, J. N., Azad, 
R. K., Padilla, P., and Mittler, R. (2017) Phylogenetic analysis of eukaryotic NEET 
proteins uncovers a link between a key gene duplication event and the evolution of 
vertebrates. Sci. Rep. 7, 42571  
 
41. Smith, L. J., Browne, S., Mulholland, A. J., and Mantle, T. J. (2008) Computational and 
experimental studies on the catalytic mechanism of biliverdin-IXbeta reductase. Biochem. 
J. 411, 475-484  
 
42. Huhner, J., Ingles-Prieto, A., Neususs, C., Lammerhofer, M., and Janovjak, H. (2015) 
Quantification of riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in 
mammalian model cells by CE with LED-induced fluorescence detection. Electrophoresis 
36, 518-525  
 
43. Heikal, A. A. (2010) Intracellular coenzymes as natural biomarkers for metabolic activities 
and mitochondrial anomalies. Biomark. Med. 4, 241-263  
 
44. Gatenby, R. A., and Gillies, R. J. (2004) Why do cancers have high aerobic glycolysis? 
Nat. Rev. Cancer 4, 891-899  
 
45. Imlay, J. A. (2006) Iron-sulphur clusters and the problem with oxygen. Mol. Microbiol. 
59, 10731082  
 
46. Kitagawa, M., Ara, T., Arifuzzaman, M., Ioka-Nakamichi, T., Inamoto, E., Toyonaga, H., 
and Mori, H. (2006) Complete set of ORF clones of Escherichia coli ASKA library (A 
Complete Set of E. coli K-12 ORF Archive): Unique Resources for Biological Research. 
DNA Res. 12, 291-299  
40 
 
CHAPTER 3. LIGHT-INDUCED RELEASE OF NITRIC OXIDE FROM 
THE NITRIC OXIDE-BOUND CDGSH-TYPE [2FE–2S] CLUSTERS IN 
MITOCHONDRIAL PROTEIN MINER2 
 
3.1 Introduction 
Iron-sulfur proteins are involved in diverse physiological functions ranging from energy 
metabolism to DNA replication and repair [1]. Most iron-sulfur clusters in proteins are ligated 
via cysteine residues. However, other amino acid residues such as histidine, glutamine, serine, or 
arginine may also provide ligands for iron-sulfur clusters in proteins [2]. A new group of iron-
sulfur proteins that contain the CDGSH (Cys-Asp-Gly-Ser-His) motifs have recently been 
identified [3]. Each CDGSH motif in the protein hosts a [2Fe–2S] cluster via a unique ligand 
arrangement of three cysteine and one histidine residues. In human mitochondria, there are three 
CDGSH-type iron-sulfur proteins [3,4]: mitoNEET [5], a mitoNEET-related protein 1 (Miner1 
or NAF-1) [6], and a mitoNEET-related protein 2 (Miner2) [7,8]. MitoNEET was initially 
identified as a target of the type II diabetes drug pioglitazone [5]. Miner1 and mitoNEET are 
homologues with 54% identity and 76% similarity. Mutations of Miner1 have been attributed to 
causing type II Wolfram Syndrome [9,10]. Both mitoNEET and Miner1 contain a 
transmembrane alpha helix in the N-terminus and a CDGSH motif in the C-terminal domain that 
hosts a [2Fe–2S] cluster [6,[11], [12], [13]]. While mitoNEET is a mitochondrial outer  
 
 
 
This chapter previously published as: Wang, Yiming, Jeonghoon Lee, and Huangen Ding. 
"Light-induced release of nitric oxide from the nitric oxide-bound CDGSH-type [2Fe–2S] 
clusters in mitochondrial protein Miner2." Nitric Oxide (2019). 
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membrane [5], Miner1 is localized in the mitochondrial outer membrane and the endoplasmic 
reticulum membrane [14]. Increasing evidence suggests that mitoNEET and Miner1 have a 
crucial regulatory role in cellular redox state, iron homeostasis, and production of reactive 
oxygen species in mitochondria [15,16]. Interestingly, unlike mitoNEET and Miner1, Miner2 is a 
soluble mitochondrial matrix protein and hosts two [2Fe–2S] clusters via two CDGSH motifs 
[7,8]. While it has been proposed that Miner2 could be involved in iron-sulfur cluster biogenesis 
in mitochondria [8], the physiological function of Miner2 remains largely elusive. 
Iron-sulfur clusters in proteins are among the primary targets of nitric oxide (NO), as NO 
has a specific reactivity with ferrous iron in proteins [[17], [18], [19], [20]]. A number of iron-
sulfur proteins have previously been characterized as NO sensors in cells [20]. It has been shown 
that iron-sulfur clusters in proteins can be readily modified by NO forming the protein-bound 
dinitrosyl iron complexes [18,21,22], the thiolate-bridged diiron tetranitrosyl complexes [23], or 
the octa-nitrosyl clusters [24], depending on specific proteins and NO concentrations used in the 
experiments. Unexpectedly, we have found that the CDGSH-type [2Fe–2S] clusters in Miner2 
are able to bind NO and form the stable NO-bound [2Fe–2S] clusters without disruption of the 
clusters [7]. In the present study, we report that the NO-bound Miner2 [2Fe–2S] clusters can 
readily release NO upon light excitation in the visible range. The UV–visible and Electron 
Paramagnetic Resonance (EPR) measurements show that the NO-bound Miner2 [2Fe–2S] 
clusters are converted to the reduced Miner2 [2Fe–2S] clusters after NO is released upon the 
light excitation, suggesting that NO binding in the reduced Miner2 [2Fe–2S] clusters is 
reversible. Furthermore, NO binding effectively inhibits the redox transition of the Miner2 [2Fe–
2S] clusters. We propose that NO may modulate the function of Miner2 in mitochondria via 
directly binding to the CDGSH-type [2Fe–2S] clusters in the protein. 
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3.2   Materials and methods 
Protein preparation 
The gene encoding the human Miner2 (containing residues 34–127) with the N-terminal 
His tag was synthesized (Genscript co.) and cloned into pET28b + plasmid for protein expression 
in E. coli cells. The cloned DNA sequence was confirmed by direct sequencing (Eurofins MWG 
Operon). Overnight E. coli cells containing expression plasmid were diluted 1:100 in freshly 
prepared LB (Luria-Bertani) medium and incubated at 37 °C with aeration (250 rpm) for 3 h, 
followed by protein induction by adding Isopropyl β-d-1-thiogalactopyranoside (200 μM) 
overnight at 18 °C. The recombinant protein was purified as described previously [25]. The 
purity of purified proteins was greater than 95% as judged by electrophoresis analysis on a 15% 
polyacrylamide gel containing SDS followed by staining with Coomassie Blue. The NO-bound 
Miner2 [2Fe–2S] clusters were prepared by treating the E. coli cells expressing human Miner2 
with NO gas (20 μM) or treating the reduced Miner2 [2Fe–2S] clusters with NO gas under 
anaerobic conditions as described previously [7]. Nitric oxide gas (Praxair Co.) was first passed 
through a soda-lima column to remove NO2 and higher nitrogen oxides before being used to 
bubble pre-degassed water in a sealed 50-ml flask for 5 min. The concentration of nitric oxide in 
the NO-saturated solution was measured using a nitric oxide electrode (World Precision 
Instrument.) [26]. The UV–visible absorption spectra were recorded in a Beckman DU640 UV–
visible spectrometer equipped with a temperature controller. The extinction coefficient of 
11.88 cm−1mM−1 was used to determine the concentration of apo-Miner2. 
Chemicals 
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NADH, isopropyl-β-d-1-thiogalactopyranoside, and kanamycin were purchased from 
Research Product International co. DAF-FM (4-amino-5-methylamino-2′,7′-difluorofluorescein) 
was purchased from ThermoFisher Scientific co. The diethylamine NONOate and Griess 
Reagent were purchased from Cayman Chemical co. FMN and other chemicals were purchased 
from Sigma co. The extinction coefficients of 6.2 mM−1cm−1 at 340 nm and 12.5 mM−1cm−1 
at 445 nm were used for determining the concentrations of NADH and FMN, respectively [27]. 
FMNH2 was prepared by using NADH and E. coli flavin reductase under anaerobic conditions 
as described in Ref. [28]. 
NO analyses 
The NO-bound Miner2 [2Fe–2S] clusters were exposed to either room light (600 Lux) or 
a Cole-Parmer 41,720 series Illuminator A (400k Lux) which provides strong visible light source 
under aerobic or anaerobic conditions. The Cole-Parmer illuminator was equipped with an 
infrared filter that reduces the transmittance of heat to the sample. The intensity of the light 
excitation was measured using a Digital Lux Meter (LX1330B, Dr. Meter). Anaerobic conditions 
were achieved by purging a gas-sealed cuvette with pure Argon gas for 10 min in dark. DAF-FM 
(4-amino-5-methylamino-2′,7′-difluorofluorescein) was used to detect NO release. DAF-FM 
interacts with NO to form a benzotriazole product which has fluorescence (ThermoFisher 
Scientific co). The fluorescence spectra were taken upon excitation at 485 nm in a 
spectrofluorometer (FP-6300 Spectrofluorometer, Jasco Co.). The fluorescence intensity was 
also measured in a plate reader (Victor3 1420 Multilabel Counter, PerkinElmer Co.) using the 
emission wavelength at 535 nm and the excitation wavelength at 485 nm. Similar results were 
obtained from the spectrofluorometer and the plate reader. The NO-releasing reagent 
diethylamine NONOate (Cayman Chemicals co.) was used as the NO standard solution. A few 
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crystals of diethylamine NONOate was first dissolved in buffer containing Tris (20 mM, pH 
10.5), and the concentration of the NONOate was determined at 250 nm using an extinction 
coefficient of 6.5 mM−1cm−1. The NONOate was then transferred to buffer containing 20 mM 
Tris (pH 8.0) and 500 mM NaCl for the NO release under anaerobic conditions. Each NONOate 
molecule releases 1.5 equivalents of NO in buffer containing 20 mM Tris (pH 8.0) and 500 mM 
NaCl after incubation at 37 °C for 10 min (Cayman Chemicals co.). 
EPR measurements 
The X-band Electron Paramagnetic Resonance (EPR) spectra were recorded using a 
Bruker model ESR-300 spectrometer equipped with an Oxford Instruments 910 continuous flow 
cryostat. Routine EPR conditions: microwave frequency, 9.47 GHz; microwave power, 
10.0 mW; modulation frequency, 100 kHz; modulation amplitude, 1.2 mT; temperature, 20 K; 
receiver gain, 2 × 105. 
Mass spectrometry measurements 
For the mass spectrometry measurements, the protein samples were dissolved in 20 mM 
ammonium acetate (pH 8.0) buffer. The protein samples were either exposed to light excitation 
(400k lux) or left in dark at room temperature. Mass spectrometry experiments were carried out 
in the LSU mass spectrometry facility. Protein concentration was about 10 μM. All experiments 
were performed with an AmaZon speed electron transfer dissociation Ion Trap mass 
spectrometer (Bruker Daltonics, Billerica, MA, USA). Sample solution was infused via an 
Apollo II electrospray ion source using a syringe pump at the flow rate of 3 μL/min. MS 
detection was performed in a full-scan mode in positive ionization enhanced resolution mode 
with the scan speed of 8100 m/z/s. The parameter settings for ESI-MS were as follows: capillary 
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voltage, 4500 V; end plate offset, −500 V; nebulizer, 8 psi; dry gas, 4 L/min; dry gas 
temperature, 100 °C. MS data were acquired from 300 to 3000 with a target mass of 1200 m/z 
and trap drive level of 100%. The software used for data processing and de-convolution was 
Compass DataAnalysis (Bruker Daltonics, Billerica, MA, USA). The mass spectrometry data 
were analyzed using mMass software [29]. 
 
3.3 Results 
The NO-bound Miner2 [2Fe–2S] clusters are light sensitive 
Purified human Miner2 [2Fe–2S] clusters are in an oxidized state which have an 
absorption peak at 458 nm. When the Miner2 [2Fe–2S] clusters are reduced, the absorption peak 
at 458 nm is shifted to 420 nm [7]. In the previous studies, we have found that the reduced 
Miner2 [2Fe–2S] clusters, but not the oxidized ones, are able to bind nitric oxide (NO) and form 
the stable NO-bound Miner2 [2Fe–2S] clusters which have a new distinct absorption peak at 
422 nm [7]. 
In the subsequent studies, we have noticed that when the NO-bound Miner2 [2Fe–2S] 
clusters were exposed to room light under aerobic conditions, the absorption peak at 422 nm of 
the NO-bound Miner2 [2Fe–2S] clusters was gradually shifted to the absorption peak at 458 nm 
of the oxidized Mienr2 [2Fe–2S] clusters (Figure. 3.1A). This observation let us to speculate that 
the NO-bound Miner2 [2Fe–2S] clusters could be light sensitive. To test the idea, the NO-bound 
Miner2 [2Fe–2S] clusters were subjected to a strong light source (400K Lux) which provides 
strong visible light under aerobic conditions. Figure. 3.1B shows that after the strong visible light 
excitation, the absorption peak at 422 nm of the NO-bound Miner2 [2Fe–2S] clusters was 
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quickly changed to the absorption peak at 458 nm of the oxidized Miner2 [2Fe–2S] clusters. The 
light excitation for about 30 s was sufficient to fully convert the NO-bound Miner2 [2Fe–2S] 
clusters) to the oxidized Miner2 [2Fe–2S] clusters under aerobic conditions (Figure. 3.1C). Thus, 
the NO-bound Miner2 [2Fe–2S] clusters are light sensitive, and the NO-bound Miner2 [2Fe–2S] 
clusters may be converted to the oxidized Miner2 [2Fe–2S] clusters by the light excitation under 
aerobic conditions. 
 
          
Figure. 3.1 The NO-bound Miner2 [2Fe–2S] clusters are light sensitive.  
A), effect of room light on the NO-bound Miner2 [2Fe–2S] clusters. Spectrum 1, the NO-bound 
(fig. caption cont'd.) 
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 Miner2 [2Fe–2S] clusters (10 μM) were incubated under dark for 1 h under aerobic conditions. 
Spectrum 2, the NO-bound Miner2 [2Fe–2S] clusters (10 μM) were incubated under room light 
for 1 h under aerobic conditions. B), effect of the light excitation on the NO-bound Miner2 [2Fe–
2S] clusters. Spectrum 1, the NO-bound Miner2 [2Fe–2S] clusters (10 μM) were incubated in 
dark for 90 s under aerobic conditions. Spectrum 2, the NO-bound Miner2 [2Fe–2S] clusters 
(10 μM) were exposed to the strong light excitation (400K Lux) for 90 s under aerobic 
conditions. C), transition from the NO-bound Miner2 [2Fe–2S] clusters to the oxidized Miner2 
[2Fe–2S] clusters upon the light excitation. The NO-bound Miner2 [2Fe–2S] clusters were 
exposed to the strong light excitation (400K Lux) for the indicated time. The absorption spectra 
were taken after each light exposure. Absorption peaks at 422 nm and 458 nm represent the NO-
bound Miner2 [2Fe–2S] clusters and the oxidized Miner2 [2Fe–2S] clusters, respectively. 
 
The NO-bound Miner2 [2Fe–2S] clusters release NO upon light excitation 
Previous studies have shown that when the NO-bound Miner2 [2Fe–2S] clusters were 
treated with Griess Reagent, nitrite was released from the NO-bound clusters due to denaturation 
of the protein [7]. Here, we used the Griess Reagent to explore whether the NO was actually 
removed from the NO-bound [2Fe–2S] clusters in Miner2 upon the light excitation. In the 
experiments, after the NO-bound Miner2 [2Fe–2S] clusters were exposed to the light excitation, 
the protein was re-purified by passing through a HiTrap Desalting column (GE Healthcare Life 
Sciences). Re-purified protein was then treated with Griess Reagents. As shown in Figure. 3.2A, 
the light excitation almost completely eliminated the acid-labile nitrite of the NO-bound [2Fe–
2S] clusters in Miner2. On the other hand, the [2Fe–2S] clusters in Miner2 remained intact after 
the light excitation, suggesting that the NO-bound Miner2 [2Fe–2S] clusters only release NO 
upon the light excitation. 
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Figure. 3.2 NO is released from the NO-bound Miner2 [2Fe–2S] clusters upon light excitation.  
A), the NO-bound Miner2 [2Fe–2S] clusters release NO after the light excitation. The Miner2 
[2Fe–2S] clusters or the NO-bound Miner2 [2Fe–2S] clusters (10 μM each) were either kept in 
dark or subjected to the light excitation (400K Lux) 60 s, followed by re-purification of the 
protein by passing through a High-Trap Desalting column. Re-purified proteins were then 
incubated with Griess Regents to determine the acid-labile nitrite. Sodium nitrite solution 
(1 mM) was used as a standard. Data were averages ± standard deviation from three experiments. 
B), mass spectra of the NO-bound Miner2 [2Fe–2S] clusters before and after the light excitation 
(400K Lux for 60 s). Spectrum 1, the NO-bound Miner2 [2Fe–2S] clusters. Spectrum 2, same as 
in spectrum 1 except after the light excitation. The mass spectra were deconvoluted using mMass 
software [29]. C), fluorescence spectra of DAF-FM incubated with the Miner2 [2Fe–2S] clusters 
under dark (spectrum 1) or after the light excitation (spectrum 2). The Miner2 [2Fe–2S] clusters 
(10 μM) were incubated with DAF-FM (4-amino-5-methylamino-2′,7′-difluorofluorescein) 
(10 μM) in dark for 2 min at room temperature under aerobic conditions. The samples were either 
(fig. caption cont'd.) 
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 kept in dark or exposed to the light excitation (400K Lux) for 60 s. The fluorescence spectra 
were taken using the excitation wavelength at 485 nm. D), fluorescence spectra of DAF-FM 
incubated with the NO-bound Miner2 [2Fe–2S] clusters under dark (spectrum 1) or after the light 
excitation (spectrum 2). Same as in C), except the NO-bound Miner2 [2Fe–2S] clusters (10 μM) 
were used. 
 
The NO-bound Miner2 [2Fe–2S] clusters were also subjected to the Electrospray 
Ionization (ESI) mass spectrometry analyses before and after the light excitation. As shown in 
Figure. 3.2B, the NO-bound Miner2 [2Fe–2S] clusters had a major mass peak at 12,889 before 
the light excitation. After the light excitation, the mass peak at 12,889 disappeared and was 
replaced with a new mass peak at 12,827, a mass decrease of 62 Da. The same mass peak at 
12,827 was observed in the purified Miner2 [2Fe–2S] clusters which represents the sum of the 
Miner2 peptide (12,784) with a likely N-terminal acetylation (43) [30] and two [2Fe–2S] clusters 
(2 × 176). As each Miner2 protein hosts two [2Fe–2S] clusters and each [2Fe–2S] cluster can 
bind one NO [7], release of two NO molecules from the NO-bound Miner2 [2Fe–2S] clusters by 
the light excitation would result in the mass decrease by 62 Da. Thus, the mass spectrometry 
results suggested that the NO-bound Miner2 [2Fe–2S] clusters release two NO molecules upon 
the light excitation. 
To further explore whether NO gas was released from the NO-bound Miner2 [2Fe–2S] 
clusters by the light excitation, we used the NO probe DAF-FM (4-amino-5-methylamino-2′,7′-
difluorofluorescein) [31]. DAF-FM is essentially nonfluorescent until it reacts with NO to form a 
fluorescent benzotriazole (Thermo Fisher Scientific co). In the experiments, the Miner2 [2Fe–
2S] clusters or the NO-bound Miner2 [2Fe–2S] clusters were incubated with DAF-FM under 
aerobic conditions, followed by the light excitation (400K Lux for 90 s). Figure. 3.2C shows that 
when the Miner2 [2Fe–2S] clusters were exposed to the light excitation, very little change of the 
fluorescence intensity of DAF-FM was observed. On the other hand, when the NO-bound 
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Miner2 [2Fe–2S] clusters mixed with DAF-FM were exposed to the light excitation, the 
fluorescence intensity of DAF-FM was significantly increased (Figure. 3.2D). Using the 
diethylamine NONOate as the NO standard solution, we estimated that about 3.4 ± 0.2 μM NO 
was released from 10 μM of the NO-bound Miner2 [2Fe–2S] clusters after the light excitation. 
 
The NO-bound Miner2 [2Fe–2S] clusters are converted to the reduced Miner2 [2Fe–2S] 
clusters by the light excitation under anaerobic conditions 
 
To determine whether oxygen is required for the light-induced NO release from the NO-
bound Miner2 [2Fe–2S] clusters, we measured the UV–visible absorption spectrum of the NO-
bound Miner2 [2Fe–2S] clusters before and after the light excitation under anaerobic conditions. 
Figure. 3.3A shows that after the light excitation, the absorption peak at 422 nm of the NO-
bound Miner2 [2Fe–2S] clusters was shifted to the peak at 420 nm. Because the absorption peak 
at 420 nm reflects the reduced Miner2 [2Fe–2S] clusters [7], the results suggested that the NO-
bound Miner2 [2Fe–2S] clusters are converted to the reduced Miner2 [2Fe–2S] clusters by the 
light excitation under anaerobic conditions. 
In previous studies, we have shown that the reduced Miner2 [2Fe–2S] clusters have a 
distinct Electron Paramagnetic Resonance (EPR) signal at g = 1.92, and the NO-bound Miner2 
[2Fe–2S] clusters are EPR-silent [7]. Here, we used EPR to examine whether the reduced Miner2 
[2Fe–2S] clusters are actually formed when the NO-bound Miner2 [2Fe–2S] clusters are exposed 
to the light excitation under anaerobic conditions. Figure. 3.3B shows that the NO-bound Miner2 
[2F–2S] clusters had an EPR signal at g = 2.04 which represented a small amount of dinitrosyl 
iron complex formed during the NO treatment of Miner2 [7]. When the NO-bound Miner2 [2Fe–
2S] clusters were exposed to the light excitation under anaerobic conditions, a new EPR signal at 
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g = 1.92 of the reduced Miner2 [2Fe–2S] clusters appeared (Figure. 3.3B). Integration of the EPR 
signal at g = 1.92 revealed that about 6.2 ± 0.5 μM of the reduced Miner2 [2Fe–2S] clusters were 
formed after 10 μM of the NO-bound Miner2 [2Fe–2S] clusters were exposed to the light 
excitation under anaerobic conditions. It should be pointed out that the EPR signal at g = 2.04 of 
the dinitrosyl iron complex was not changed upon the light excitation (Figure. 3.3B), indicating 
that dinitrosyl iron complex was not light sensitive. Taken together, the results established that 
the NO-bound Miner2 [2Fe–2S] clusters are converted to the reduced Miner2 [2Fe–2S] clusters 
by the light excitation under anaerobic conditions. 
 
 
                 
Figure. 3.3 Oxygen is not required for the light-induced NO release from the NO-bound Miner2 
[2Fe–2S] clusters.  
A), UV–visible absorption spectra of the NO-bound Miner2 [2Fe–2S] clusters before and after 
the light excitation under anaerobic conditions. The NO-bound Miner2 [2Fe–2S] clusters 
(10 μM) were incubated under anaerobic conditions, followed by exposure to the light excitation 
(400K Lux) for 0, 5, 10, 15, and 20 s. Spectra were taken after each light excitation. B), EPR 
spectra of the NO-bound Miner2 [2Fe–2S] clusters. Spectrum 1, the NO-bound Miner2 [2Fe–2S] 
clusters (10 μM). Spectrum 2, same as in spectrum 1 except after the light excitation (400K Lux 
for 60 s) under anaerobic conditions. The results are representatives from three independent 
experiments. 
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NO binding inhibits the redox transition of the Miner2 [2Fe–2S] clusters 
Like the mitoNEET [2Fe–2S] clusters [28], the Miner2 [2Fe–2S] clusters can be reduced 
by the reduced flavin mononucleotide (FMNH2) and oxidized by oxygen. Figure. 3.4A shows 
that the oxidized Miner2 [2Fe–2S] clusters were readily reduced by FMNH2 under anaerobic 
conditions, and that the reduced Miner2 [2Fe–2S] clusters were re-oxidized after exposure to air, 
indicating that the Miner2 [2Fe–2S] clusters can undergo redox transition. In contrast, the NO-
bound Miner2 [2Fe–2S] clusters could not be reduced by FMNH2 or oxidized by oxygen, as the 
absorption peak at 422 nm of the NO-bound Miner2 [2Fe–2S] clusters remained the same upon 
addition of FMNH2 or exposure to air (Figure. 3.4B). The results suggested that the NO-bound 
Miner2 [2Fe–2S] clusters are resistant to redox transition. When the NO-bound Miner2 [2Fe–2S] 
clusters were exposed to the light excitation, the NO-bound Miner2 [2Fe–2S] clusters quickly 
became the reduced Miner2 [2Fe–2S] clusters under anaerobic conditions, and further exposure 
to air led to oxidation of the reduced Miner2 [2Fe–2S] clusters (Figure. 3.4C). The results 
suggested that release of NO from the NO-bound Miner2 [2Fe–2S] clusters restores the redox 
transition activity of the Miner2 [2Fe–2S] clusters. 
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Figure. 3.4 NO inhibits the redox transition of the Miner2 [2Fe–2S] clusters.  
A), reduction and oxidation of the Miner2 [2Fe–2S] clusters. Purified Miner2 (10 μM) (spectrum 
1) was incubated with FMN (0.1 μM), NADH (20 μM) and E. coli flavin reductase (0.1 μM) for 
5 min under anaerobic conditions (spectrum 2). The sample was then exposed to air for 10 min 
(spectrum 3). B), effect of oxygen and FMNH2 on the NO-bound Miner2 [2Fe–2S] clusters. The 
NO-bound Miner2 [2Fe–2S] clusters (10 μM) (spectrum 1) was incubated with FMN (0.1 μM), 
NADH (20 μM) and E. coli flavin reductase (0.1 μM) for 5 min under anaerobic conditions 
(spectrum 2). The sample was then exposed to air for 10 min (spectrum 3). C), oxidation of the 
NO-bound Miner2 [2Fe–2S] clusters by the light excitation and air. The NO-bound Miner2 
[2Fe–2S] clusters (10 μM) (spectrum 1) were exposed to the light excitation (400K Lux) for 30 s 
under anaerobic conditions (spectrum 2), followed by exposure to air for 10 min (spectrum 3). 
Absorption peaks at 422 nm, 420 nm, and 458 nm represent the NO-bound Miner2 [2Fe–2S] 
clusters, the reduced Miner2 [2Fe–2S] clusters, and the oxidized Miner2 [2Fe–2S] clusters, 
respectively. 
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3.4   Discussion 
In previous studies, we have shown that the mitochondrial matrix protein Miner2 [2Fe–
2S] clusters have a unique activity to bind NO and form the stable NO-bound [2Fe–2S] clusters 
[7]. Here, we report that the NO-bound [2Fe–2S] clusters in Miner2 are light sensitive. Upon the 
light excitation, the NO-bound Miner2 [2Fe–2S] clusters release NO and become the reduced 
Miner2 [2Fe–2S] clusters under anaerobic conditions. Additional studies further reveal that 
binding of NO effectively inhibits the redox transition of the Miner2 [2Fe–2S] clusters, 
indicating that NO may modulate the physiological function of Miner2 in mitochondria by 
directly binding to the CDGSH-type [2Fe–2S] clusters. 
NO has a high reactivity with heme and iron-sulfur clusters in proteins [32,33]. The 
binding of NO to heme has been extensively investigated in proteins such as soluble guanylate 
cyclase [34]. However, much less has been known about the specific interactions between NO 
and iron-sulfur clusters in proteins. Previous studies from different research groups including 
ours have shown that iron-sulfur clusters in proteins are readily disrupted by NO, forming the 
dinitrosyl iron complex [18,21,22], the thiolate-bridged diiron tetranitrosyl complex [23], or the 
octa-nitrosyl cluster [24]. To the best of our knowledge, the Miner2 CDGSH-type [2Fe–2S] 
clusters represent the first example that the [2Fe–2S] clusters can bind NO and form stable NO-
bound clusters [7]. The unique NO binding activity of the CDGSH-type [2Fe–2S] cluster in 
Miner2 is likely due to its unusual ligand arrangement of three cysteine and one histidine 
residues [8]. In the CDGSH-type [2Fe–2S] clusters, one of the iron atoms is ligated via two 
cysteine residues and the other iron via one cysteine and one histidine residues [8]. The iron 
center ligated via cysteine/histidine residues in the [2Fe–2S] cluster is most likely redox active 
[35]. In this context, we propose that NO binds to the ferrous iron in the reduced Miner2 [2Fe–
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2S] cluster (Figure. 3.5), which is reminiscent of the NO binding in the ferrous heme in proteins 
[34]. The NO binding affinity for the ferrous heme in proteins is extremely high with the binding 
constant of about 1011 M−1 [36]. On the other hand, the NO binding affinity for the ferric heme 
in proteins is relatively weaker with the binding constant in the range of 103 to 105 M−1 [37]. 
Accordingly, we find that the oxidized Miner2 [2Fe–2S] clusters fail to bind NO, and only the 
reduced Miner2 [2Fe–2S] clusters are able to bind NO with a high binding affinity [7]. Since the 
redox midpoint potent (Em) of the CDGSH-type [2Fe–2S] clusters in mitoNEET is about 
0 mV at pH 7.0 [38], it is most likely that the [2Fe–2S] clusters in Miner2 are in a reduced state 
in mitochondria [7]. Thus, the Miner2 [2Fe–2S] clusters are capable of binding NO under 
physiological conditions. 
                                
Figure. 3.5 Proposed model for the NO-mediated inhibition of the redox transition of the Miner2 
[2Fe–2S] clusters. Mitochondrial protein Miner2 contains two [2Fe–2S] clusters. Only one of the 
[2Fe–2S] clusters is shown. In the reduced Miner2 [2Fe–2S] cluster, the iron atom ligated with 
his/cys is in ferrous state and can be oxidized by oxygen. When NO binds to the ferrous iron 
atom in the reduced [2Fe–2S] cluster, the cluster can no longer be oxidized by oxygen or reduced 
by FMNH2. When NO is released from ten NO-bound Miner2 [2Fe–2S] clusters by light 
excitation, the oxidation of the reduced Miner [2Fe–2S] clusters by oxygen is restored. 
 
While the NO-bound Miner2 [2Fe–2S] clusters are stable under aerobic or anaerobic 
conditions, they are highly sensitive to visible light (Figure. 3.1). The mass spectrometry 
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analyses showed that two NO molecules may be released from the NO-bound Miner2 [2Fe–2S] 
clusters by the light excitation (Figure. 3.2B). The EPR and UV–visible absorption 
measurements further revealed that the NO-bound Miner2 [2Fe–2S] clusters are converted to the 
reduced Miner2 [2Fe–2S] clusters upon the light excitation under anaerobic conditions (Figure. 
3.3), demonstrating that the NO binding in the reduced Miner2 [2Fe–2S] clusters is reversible. 
We were unable to observe the re-binding of NO to the reduced Miner2 [2Fe–2S] clusters after 
the light excitation, likely due to the diffusion of NO and/or the reaction of NO with other 
reactants in the solution. However, addition of extra NO to the reaction solution resulted in re-
binding of NO to the reduced Miner2 [2Fe–2S] clusters in dark (data not shown), further 
supporting a notion that the reduced Miner2 [2Fe–2S] clusters can reversibly bind NO. 
Like the mitoNEET [2Fe–2S] clusters, the Miner2 [2Fe–2S] clusters can be readily 
reduced by FMNH2 and oxidized by oxygen. However, the NO-bound Miner2 [2Fe–2S] clusters 
are resistant to reduction or oxidation (Figure. 3.4B). When NO is released from the NO-bound 
Miner2 [2Fe–2S] clusters by the light excitation, the reduced Miner2 [2Fe–2S] clusters can be 
re-oxidized by oxygen (Figure. 3.4C), suggesting that NO binding effectively blocks the redox 
transition of the Miner2 [2Fe–2S] clusters (Figure. 3.5). It has been reported that the 
mononuclear iron center in nitrile hydratase from Rhodococcus sp. N-771 has a strong binding 
activity for NO [39]. Purified nitrile hydratase is inactive due to NO binding in the mononuclear 
iron center, and light excitation releases NO from nitrile hydratase and activates the enzyme 
activity [40]. For the NO-bound Miner2 [2Fe–2S] clusters, release of NO by light excitation 
appears to also restore the redox transition of the Miner2 [2Fe–2S] clusters. While the 
mechanism by which the light-induced release of NO from the NO-bound Miner2 [2Fe–2S] 
clusters is not fully understood, our results strongly suggested that the NO binding in the reduced 
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Miner2 [2Fe–2S] clusters is reversible, and NO may change the physiological activity of Miner2 
in mitochondria by directly binding to the [2Fe–2S] clusters. Since there are many CDGSH-type 
[2Fe–2S] proteins found in human cells [4], the reversible NO binding in the Miner2 [2Fe–2S] 
clusters may represent a novel example of NO regulation via the CDGSH-type [2Fe–2S] clusters 
in proteins. 
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CHAPTER 4. CONCLUSIONS 
Human mitoNEET has a key role in iron homeostasis, production of reactive oxygen 
species and energy metabolism in mitochondria.  Here we find that mitoNEET is a novel electron 
transfer protein that can catalyzes the electron transfer from NADH to oxygen or ubiquinone. We 
also identify a unique binding site of flavin mononucleotide (FMN) binding site in mitoNEET, 
which is different from but overlaps with the binding sites of type II diabetes drug Pioglitazone 
in mitoNEET.  Pioglitazone or its homologs can effectively inhibit the electron transfer  activity 
of mitoNEET, apparently by competing with FMN binding in mitoNEET.  We propose that 
mitoNEET may promote glycolysis in cytosol by oxidizing cytosolic NADH and regulate energy 
metabolism in normal and cancer cells.  We also find that the human Miner2 [2Fe-2S] clusters 
can reversibly bind nitric oxide without disruption of the clusters.  Binding of nitric oxide to the 
[2Fe-2S] clusters in Miner2 effectively inhibit the electron transfer activity of Miner2, 
demonstrating that nitric oxide may regulate energy metabolism by directly binding to the [2Fe-
2S] clusters in the NEET-proteins in mitochondria. 
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